Mpox (monkeypox) risk and mortality associated with HIV infection: a national case-control study in Nigeria.

Adesola Yinka-Ogunleye, Mahmood Dalhat, Afolabi Akinpelu, Olusola Aruna, Fatima Garba, Adama Ahmad, Adesola Adeleye, Iliya Botson, Bamidele Oluwafemi, Oladipo Ogunbode, Lateefat Amao, Udeme Ekripo, Gambo Gumel Aliyu, Ifedayo Adetifa, Chikwe Ihekweazu, Ibrahim Abubakar
Author Information
  1. Adesola Yinka-Ogunleye: Department of Surveillance and Epidemiology, Nigeria Centre for Disease Control, Abuja, Nigeria adesola.yinka-ogunleye.20@ucl.ac.uk.
  2. Mahmood Dalhat: African Field Epidemiology Network, Abuja, Nigeria.
  3. Afolabi Akinpelu: National Reference Laboratory, Nigeria Centre for Disease Control, Abuja, Federal Capital Territory, Nigeria.
  4. Olusola Aruna: IHR Strengthening Programme in Nigeria, UK Health Security Agency, London, UK.
  5. Fatima Garba: African Field Epidemiology Network Nigeria, Abuja, Nigeria.
  6. Adama Ahmad: National Reference Laboratory, Nigeria Centre for Disease Control, Abuja, Federal Capital Territory, Nigeria.
  7. Adesola Adeleye: National Reference Laboratory, Nigeria Centre for Disease Control, Abuja, Federal Capital Territory, Nigeria.
  8. Iliya Botson: National Reference Laboratory, Nigeria Centre for Disease Control, Abuja, Federal Capital Territory, Nigeria.
  9. Bamidele Oluwafemi: National Reference Laboratory, Nigeria Centre for Disease Control, Abuja, Federal Capital Territory, Nigeria.
  10. Oladipo Ogunbode: Prevention Programmes and Knowledge Management, Nigeria Centre for Disease Control, Abuja, Federal Capital Territory, Nigeria.
  11. Lateefat Amao: Prevention Programmes and Knowledge Management, Nigeria Centre for Disease Control, Abuja, Federal Capital Territory, Nigeria.
  12. Udeme Ekripo: University of Uyo Teaching Hospital, Uyo, Nigeria.
  13. Gambo Gumel Aliyu: Epidemiology and Prevention, Institute of Human Virology, Baltimore, Maryland, USA.
  14. Ifedayo Adetifa: Nigeria Centre for Disease Control, Abuja, Nigeria.
  15. Chikwe Ihekweazu: Nigeria Centre for Disease Control, Abuja, Nigeria.
  16. Ibrahim Abubakar: Institute of Global Health, University College London, London, UK.

Abstract

INTRODUCTION: Recent outbreaks of mpox are characterised by changes in the natural history of the disease, the demographic and clinical characteristics of the cases, and widening geographical distribution. We investigated the role of HIV and other sexually transmitted infections (STIs) coinfection among cases in the re-emergence of mpox to inform national and global response.
METHODS: We conducted a national descriptive and case-control study on cases in the 2017-2019 Nigerian mpox outbreak. Mpox cases were age, sex and geographical area matched each with two randomly selected controls from a representative national HIV/AIDS survey. Logistic regression was used to investigate the association between HIV infection and the risk of mpox acquisition and death.
RESULTS: Among 204 suspected mpox cases, 86 were confirmed (median age 31 years (IQR 27-38 years), mostly males (61 cases, 70.9%). Three-fifths of mpox cases had serological evidence of one or more STIs with 27.9% (24/86) coinfected with HIV. The case fatality rate was 9.4% (8/86) and 20.8% (5/24) overall and in HIV positive cases respectively. Mpox cases were more likely to have HIV coinfection compared with an age, gender and geography-matched control group drawn from the general population (OR 45 (95% CI 6.1 to 333.5, p=0.002) and when compared with non mpox rash cases (7.29 (95% CI 2.6 to 20.5, p<0.0001)). HIV coinfection and young age were associated with mortality among mpox cases (aOR 13.66 (95% CI 1.88 to 98.95, p=0.010) and aOR 0.90 (0.82-0.97, p=0.008), respectively).
CONCLUSION: HIV infection was associated with a higher risk of contracting and dying from mpox. Children are also at high risk of death. STIs in mpox cases may be suggestive of high-risk sexual behaviours among these individuals.

Keywords

HIV

References

Br Med Bull. 1998;54(3):693-702 [PMID: 10326294]
Update Univ S C Dep Music. 2023 Feb;41(2):28-37 [PMID: 37038372]
Trends Microbiol. 2012 Feb;20(2):80-7 [PMID: 22239910]
Infect Dis Clin North Am. 2019 Dec;33(4):1027-1043 [PMID: 30981594]
Emerg Infect Dis. 2001 May-Jun;7(3):434-8 [PMID: 11384521]
Euro Surveill. 2022 Jun;27(22): [PMID: 35656830]
BMJ. 2022 Jul 28;378:e072410 [PMID: 35902115]
J Infect Dis. 2005 Feb 1;191(3):372-81 [PMID: 15633096]
J Infect Dis. 1987 Aug;156(2):293-8 [PMID: 3036967]
Emerg Infect Dis. 2018 Jun;24(6):1149-1151 [PMID: 29619921]
Int J Epidemiol. 1988 Sep;17(3):643-50 [PMID: 2850277]
Front Public Health. 2018 Sep 04;6:241 [PMID: 30234087]
MMWR Morb Mortal Wkly Rep. 2018 Mar 16;67(10):306-310 [PMID: 29543790]
Expert Rev Anti Infect Ther. 2020 May;18(5):389-392 [PMID: 32096659]
Lancet Infect Dis. 2018 Mar;18(3):246 [PMID: 29361427]
Lancet Infect Dis. 2019 Aug;19(8):872-879 [PMID: 31285143]
Clin Infect Dis. 2020 Nov 5;71(8):e210-e214 [PMID: 32052029]
Clin Infect Dis. 2014 Jan;58(2):260-7 [PMID: 24158414]
N Engl J Med. 1998 Aug 20;339(8):556-9 [PMID: 9709051]
Lancet Infect Dis. 2004 Jan;4(1):15-25 [PMID: 14720564]
HIV Med. 2023 Apr;24(4):389-397 [PMID: 36059149]
MMWR Morb Mortal Wkly Rep. 2022 Sep 09;71(36):1141-1147 [PMID: 36074735]
N Engl J Med. 2022 Dec 22;387(25):e69 [PMID: 36546638]
N Engl J Med. 2004 Jan 22;350(4):342-50 [PMID: 14736926]
J Infect Dis. 2022 Apr 19;225(8):1367-1376 [PMID: 32880628]
Sex Transm Infect. 2006 Dec;82(6):491-5 [PMID: 16757513]

MeSH Term

Adult
Female
Humans
Male
Case-Control Studies
Coinfection
HIV Infections
Mpox, Monkeypox
Nigeria

Word Cloud

Similar Articles

Cited By